Effect of tris-(hydroxymethyl)-aminomethane on experimental focal cerebral ischemia.
Systemic and focal cerebral acidosis is considered deleterious to cell metabolism and neuronal recovery. We investigated the immediate effect of tris-(hydroxymethyl)-aminomethane (THAM), an alkalizing agent, on focal cerebral ischemia produced by occlusion of the left middle cerebral artery (MCA) in cats with systemic acidosis. Occlusion of MCA resulted in prompt decreases in local cerebral blood flow of the ipsilateral marginal and ectosylvian gyri from 47.7 ml/100 g per minute in control to 32.3 ml/100 g per minute and 8.3 ml/100 g per minute, respectively. In the control group, physiological saline was infused continuously and the treated group received 0.3 M THAM to normalize systemic and focal cerebral acidosis. There were no significant changes in the systemic arterial pressure, arterial PO2 and PCO2 throughout the experiments in the two groups. Arterial pH decreased from 7.42 to 7.30 in the control, while it remained normal during THAM treatment. Extracellular pH of the marginal gyrus (peri-infarct zone) decreased from 7.39 to 6.87 with 6 h ischemia in the control group. In THAM infusion, extracellular pH was kept between 7.26 and 7.29, which was significantly higher than the control group. THAM significantly decreased infarct volume and lactate and water contents of the gray matter in the marginal gyrus at 6 h after occlusion. It is concluded that THAM infusion immediately after ischemia onset is considered effective in improving acidosis at the site of ischemic penumbra and consequently reduces lactate production, brain edema, and infarct volume.
Nagao
S
S
Department of Neurological Surgery, Kagawa Medical School, Japan.
Kitaoka
T
T
Fujita
K
K
Kuyama
H
H
Ohkawa
M
M
D000136:Acid-Base Equilibrium; D000138:Acidosis / Q000150:complications / Q000188:drug therapy*; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000150:complications; D001784:Blood Gas Analysis; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002560:Cerebrovascular Circulation / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D002546:Ischemic Attack, Transient / Q000150:complications / Q000188:drug therapy*; D014325:Tromethamine / Q000494:pharmacology*
D014325:Tromethamine